Jianxin Wang

Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model

B. Edil, T. Liang, elliot k fishman, 2022, Cancer letters.

Isoliquiritigenin inhibits cell proliferation and migration through the PI3K/AKT signaling pathway in A549 lung cancer cells.

Haitao Liu, T. Tian, Jinpeng Sun, 2018, Oncology letters.

CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma

A. Narang, K. Fujiwara, Qihong Zhao, 2022, The Journal of experimental medicine.

Inhibition of focal adhesion kinase enhances antitumor response of radiation therapy in pancreatic cancer through CD8+ T cells

elliot k fishman, D. Laheru, Zaiqi Wang, 2021, Cancer biology & medicine.

Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects

Chun-hui Yuan, Jianxin Wang, N. Niu, 2020, Chronic diseases and translational medicine.

Engineered TCR T-cell therapy targeting mass spectrometry-identified natural epitope in PDAC.

Juan Fu, Jun Yu, Lei Zheng, 2023, Cancer letters.

Dual stromal targeting sensitizes pancreatic adenocarcinoma for anti-PD-1 therapy.

K. Chan, S. Pandol, J. Gong, 2022, Gastroenterology.